- Home
- INTZ vs VYNE Comparison
INTZ vs VYNE Comparison
Compare INTZ & VYNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INTZ | VYNE |
|---|---|---|
| Founded | 1983 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Communications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.9M | 20.4M |
| IPO Year | 2020 | 2017 |
Fundamental Metrics
Financial Performance| Metric | INTZ | VYNE |
|---|---|---|
| Price | $0.90 | $0.62 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 1 |
| Target Price | ★ $5.75 | N/A |
| AVG Volume (30 Days) | 145.4K | ★ 160.9K |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 71.78 | 33.33 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $7,015,000.00 | N/A |
| Revenue This Year | $36.12 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 21.56 | N/A |
| 52 Week Low | $0.75 | $0.29 |
| 52 Week High | $2.64 | $1.98 |
Technical Indicators
Market Signals| Indicator | INTZ | VYNE |
|---|---|---|
| Relative Strength Index (RSI) | 44.97 | 53.09 |
| Support Level | $0.86 | $0.56 |
| Resistance Level | $1.17 | $0.75 |
| Average True Range (ATR) | 0.08 | 0.02 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 36.03 | 65.20 |
Price Performance
Historical ComparisonAbout INTZ Intrusion Inc.
Intrusion Inc is a cybersecurity company based in Plano, Texas. The company offers its customers access to its exclusive threat intelligence database containing the historical data, known associations, and reputational behavior of Internet Protocol addresses. Its platform combines threat intelligence, malicious traffic identification, and automated threat response, and is designed to help organizations proactively identify and stop malicious activity in their networks. Its solutions include INTRUSION Shield, INTRUSION TraceCop, and INTRUSION Savant. The company operates in single segment.
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary and differentiated therapies for the treatment of immuno-inflammatory conditions. The company is also in the pre-clinical stages of research, develop and commercialize products containing small molecule bromodomain and extra-terminal domain (BET) inhibitors for the treatment of any disease, disorder or condition in human. Its products include AMZEEQ, ZILXI, and FCD105.